Belite Bio, Inc Research and Development Expense
Belite Bio, Inc (BLTE) reported Research and Development Expense of $45.38 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-03-31
| Period end | Research and Development Expense 12 month |
|---|---|
| 2025-12-31 | $45.38M 20-F · filed 2026-03-31 |
| 2024-12-31 | $29.94M 20-F · filed 2026-03-31 |
| 2023-12-31 | $24.84M 20-F · filed 2026-03-31 |
| 2022-12-31 | $8.87M 20-F · filed 2025-03-17 |
| 2021-12-31 | $7.42M 20-F · filed 2024-03-12 |
| 2020-12-31 | $3.69M 20-F · filed 2023-03-31 |